Negative impactIPO
Manipal Health IPO Last Day: Issue Subscribed Only 47% So Far, GMP At 1%; Should You Apply?
News18 1 hr ago·31 Jul 2026, 2:17 am
IPO News18
The final day for subscription for the Manipal Health IPO has arrived, but the response has been underwhelming. The issue has been subscribed to only 47% so far, indicating a lukewarm reception from investors. This low demand suggests that the IPO is currently trading at a discount in the grey market, with the GMP (Grey Market Premium) sitting at 1%.
For potential investors, this situation implies that the listing price may be close to the issue price. The lack of strong subscription figures means that the stock may face resistance upon listing, as there is limited institutional support to push the price higher. The grey market premium of 1% further reinforces the view that the listing may not generate significant immediate gains.
Investors should focus on the company's long-term fundamentals and the healthcare sector's growth prospects rather than short-term listing gains. The stock's performance post-listing will depend on its ability to deliver on its business promises. It is advisable to wait for the listing price and market conditions before making a decision.
Key takeaways
- Category: IPO.
- AI reads the tone as negative (potentially bearish) for the stock.
Why it matters
A routine update. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.
